Roivant Sciences

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Here’s How Much You Would Have Made Owning Roivant Sciences Stock In The Last 5 Years (öffnet in neuem Tab)

  Benzinga · 01.10.2026

• Why Did DELL, ROIV, SHEL Stocks Surge To 52-Week Highs Today? (öffnet in neuem Tab)

  Stocktwits · 01.10.2026

• Form 144 Roivant Sciences Ltd. For: 1 October By Investing.com (öffnet in neuem Tab)

  Investing.com Canada · 01.10.2026

• Roivant Sciences Ltd. (ROIV) Stock Forecasts (öffnet in neuem Tab)

  Yahoo! Finance Canada · 01.10.2026

• After a $7.15M August sale, Roivant (ROIV) officer Eric Venker proposes another share sale. (öffnet in neuem Tab)

  Stock Titan · 30.09.2026

• Roivant Sciences Ltd. (ROIV) Stock Price, News, Quote & History (öffnet in neuem Tab)

  Yahoo! Finance Canada · 30.09.2026

• Roivant Sciences gains as investors appear to keep rewarding recent clinical and regulatory momentum (öffnet in neuem Tab)

  Quiver Quantitative · 28.09.2026

• Roivant Sciences Targets LISRAYA Launch, Key Pipeline Readouts in Next 12 Months (öffnet in neuem Tab)

  es.tradingview.com · 28.09.2026

• Form 4 Roivant Sciences Ltd. For: 28 September By Investing.com (öffnet in neuem Tab)

  Investing.com Nigeria · 28.09.2026

• Cantor Fitzgerald reiterates Roivant Sciences stock rating (öffnet in neuem Tab)

  Investing.com · 24.09.2026

• Roivant Sciences (ROIV) Reiterated at Overweight by Cantor Fitzgerald (öffnet in neuem Tab)

  StreetInsider · 24.09.2026

• Roivant slips on trial setback for Immunovant (ROIV:NASDAQ) (öffnet in neuem Tab)

  Seeking Alpha · 23.09.2026

• Roivant halts IMVT-1402 development in cutaneous lupus after trial miss (öffnet in neuem Tab)

  StreetInsider · 23.09.2026

• Behavioral Patterns of ROIV and Institutional Flows (öffnet in neuem Tab)

  Stock Traders Daily · 23.09.2026

• Roivant (ROIV) CAO uses 3,880 shares to cover RSU taxes (öffnet in neuem Tab)

  Stock Titan · 23.09.2026

• Roivant Plunges After Founder’s Billion-Dollar Stock Sale (öffnet in neuem Tab)

  TipRanks · 22.09.2026

• Roivant (ROIV): $9 Billion Sales Potential Faces a Commercialization Test (öffnet in neuem Tab)

  Yahoo Finance · 22.09.2026

• Roivant Sciences (ROIV) CFO now holds 269,681 shares after RSU tax withholding (öffnet in neuem Tab)

  Stock Titan · 22.09.2026

• New stock awards for Roivant Sciences (ROIV) director vest in 2027 (öffnet in neuem Tab)

  Stock Titan · 18.09.2026

• What Is Roivant Sciences (ROIV) Signaling With Its Positive PH ILD Trial Data? (öffnet in neuem Tab)

  Yahoo Finance · 18.09.2026

• Roivant Sciences (ROIV) gives director new options and RSUs (öffnet in neuem Tab)

  Stock Titan · 18.09.2026

• Roivant Sciences (ROIV) grants director stock awards vesting in 2027 (öffnet in neuem Tab)

  Stock Titan · 18.09.2026

• Roivant Sciences (ROIV) director now holds 8.97M shares (öffnet in neuem Tab)

  Stock Titan · 18.09.2026

• Roivant Sciences (ROIV) director receives new 2027-vesting equity grant (öffnet in neuem Tab)

  Stock Titan · 18.09.2026

• Director at Roivant (ROIV) receives new stock awards (öffnet in neuem Tab)

  Stock Titan · 18.09.2026

• JPMorgan reiterates Roivant Sciences stock rating on survey data By Investing.com (öffnet in neuem Tab)

  Investing.com India · 17.09.2026

• Roivant Sciences (ROIV) director sells 5,112 shares under pre-set plan (öffnet in neuem Tab)

  Stock Titan · 17.09.2026

• Roivant Sciences (ROIV) Reiterated at Overweight by JPMorgan on Lisraya Feedback (öffnet in neuem Tab)

  StreetInsider · 17.09.2026

• Roivant Sciences (NASDAQ: ROIV) director sells 4,938 shares under 10b5-1 plan (öffnet in neuem Tab)

  Stock Titan · 17.09.2026

• Stifel initiates Roivant Sciences stock with buy rating, $51 target (öffnet in neuem Tab)

  Investing.com · 16.09.2026